Patients treated for epilepsy with phenytoin develop a significant fall in serum IgA. We investigated this association because it may be a model for selective IgA deficiency. Phenytoin (20pg/ml) was added to human lymphocyte cultures stimulated by pokeweed mitogen (PWM). After 6 days in culture lymphocyte proliferation was measured by 'thymidine incorporation. B-cell differentiation and relative proportions of IgG-, IgM-and IgA-containing (2) 20(2) p=NS for each These results suggest that phenytoin a t therapeutic levels does not interfere with PWM-stimulated thymidine incorporation. B-cell differentiation t o PC was reduced but isotype distribution was unchanged. This latter finding is consistant with the published observation that IgG and IgM, a s well a s IgA, a r e lowered in some patients on phenytoin. The predominance of the in vivo effect on IgA may be due t o a genetic predisposition, interference with T-cell cooperation needed for 6-cell production of IgA, or direct interference by the phenytoin molecule in the biochemical basis of 6-cell differentiation and proliferation. previous s t u d i e s by o t h e r s have suggested t h a t HIE i n f e c t i o n above age 18 months and a delayed maturation of t h e i n f a n t ' s Ab
20(2) p=NS for each These results suggest that phenytoin a t therapeutic levels does not interfere with PWM-stimulated thymidine incorporation. B-cell differentiation t o PC was reduced but isotype distribution was unchanged. This latter finding is consistant with the published observation that IgG and IgM, a s well a s IgA, a r e lowered in some patients on phenytoin. The predominance of the in vivo effect on IgA may be due t o a genetic predisposition, interference with T-cell cooperation needed for 6-cell production of IgA, or direct interference by the phenytoin molecule in the biochemical basis of 6-cell differentiation and proliferation. previous s t u d i e s by o t h e r s have suggested t h a t HIE i n f e c t i o n above age 18 months and a delayed maturation of t h e i n f a n t ' s Ab response t o HIE-CP may be associated with p a r t i c u l a r Km a l l o t y p e antigens of the kappa l i g h t chain. To b e t t e r understand t h e mechanism of this a s s o c i a t i o n , t h e l i g h t chain type d i s t r i b u t i o n of a n t i c a p s u l a r Ab induced by HIE-CP immunization and HIE infect i o n was determined by an enzyme-linked immunosorbent assay. The l i g h t chain of immunization-induced antibody was predominantly of t h e kappa chain type i n 19 of 25 a d u l t s e r a and almost exclus i v e l y kappa chain i n 9 of t h e s e sera. Kappa chain r e s t r i c t i o n did not c o r r e l a t e with t h e pre-immunization l i g h t chain type d i s t r i b u t i o n nor the post-immunization antibody level. Restrict i o n p e r s i s t e d up t o 30 months a f t e r immunization. The convalescent s e r a of 9 of 10 p a t i e n t s recovering from HIE disease showed kappa chain r e s t r i c t i o n . In c o n t r a s t , antibody t o tetanus toxoid and t h e CP of S. pneumoniae type 3 in both groups of s e r a did not show l i g h t chain r e s t r i c t i o n . This l i g h t chain r e s t r i c t i o n of a n t i c a p s u l a r Ab may be a p a r t i a l explanation of t h e described association of delayed maturation of immunity t o t h e HIE-CP with p a r t i c u l a r Km a l l o t y p e antigens.
LS A SERUM INHIBITOR RESPONSIBLE FOR THE HIGH INCI-DENCE OF SEVERE COMBINED IMMUNODEFICIENCY CSCID) IN
928 NATIVE AMERICANS? James F. Jones, Linda Minnich, Vincent A. F u l g i n i t i , Univ. of Arizona, University Hosp., Dept.
of P e d i a t r i c s and Pathology, Tucson.
The incidence of SCID i n one American Indian t r i b e approximates 113500 l i v e b i r t h s . I n an ongoing attempt t o evaluate t h i s unexplained phenomenon, serum from 3 p a t i e n t s with SCID was examfned f o r i n h i b i t i o n of normal lymphocyte response t o mitogens and antigens. Responses were diminished from 33 t o 99.9% with PHA, Con A, and PWM, and 22% with C. albicans when p a t i e n t serum o r plasma was s u b s t i t u t e d f o r AB plasma. I f p a t i e n t s e r a and AB s e r a were both present, i n h i b i t i o n ranged from 13-91%. A 24-hour incubation period was required t o prevent removal of t h e inhibitory e f f e c t by washing of normal c e l l s . Washing of p a t i e n t c e l l s did not r e s t o r e function. The i n h i b i t o r e f f e c t was diminished a f t e r temporarily successful treatment with cultured thymus fragments i n 2 p a t i e n t s , and following plasma and RBC infusion. Heterologous RBCs and PMNs, but not lymphocytes, adsorbed t h e inhib i t i o n a c t i v i t y . PMN function Cchemiluminescence) was not a l t e red by t h e s e r a . Analysis of t h e purine pathway by F. Schmalsteig CGalveston) showed t h e presence of ensymes and no toxic metabol i t e s . I n h i b i t o r a c t i v i t y was not removed by d i a l y s i s nor heating a t 5 6 '~ f o r 30 min., and was always present i n multiple samp l e s . Serum from one of 4 caucasian SCID p a t i e n t s (courtesy of A. Goldman) suppressed only t h e Con A response. The r e l a t i o n of t h i s i n h i b i t i o n t o t h e etiology of SCID i n these p a t i e n t s is unc e r t a i n , but a d d i t i o n a l s t u d i e s a r e warranted.
INCOMPLETE LYMPHOCYTE DIFFERENTIATION I N B CELL LINES
929 FROM IMMUNODEFICIENT PATIENTS. James F. Jones, Hans D. Ochs, Frank L. Meyskens. Univ. of Ariz., Depts.
of P e d i a t r i c s and Medicirie, Tucson, Univ. of Wash., Dept. of P e d i a t r i c s , S e a t t l e .
EBV-infected c e l l l i n e s from 31 immunodeficient (ID) p a t i e n t s and 1 normal individual, and 7 spontaneous c e l l l i n e s from cancer p a t i e n t s were assayed f o r terminal deoxynucleotidyl t r a n s f e r a s e (TdT) a c t i v i t y . TdT is found primarily i n pre-T c e l l s i n bone marrow, thymus, and i n some a c u t e leukemias; i t i s not present i n mature c i r c u l a t i n g B or T c e l l s . Twenty-nine l i n e s were studied with and without ATP, a s p e c i f i c TdT i n h i b i t o r , and 11 l i n e s without ATP. A s a reference, 8402 c e l l s (T c e l l l i n e ) had 0,400 u n i t s (U) of a c t i v i t y with >80% i n h i b i t i o n . Seven of 11 l i n e s had 0.018 t o 0.095 U of a c t i v i t y ; 4 of these were from I D pat i e n t s . Twelve of 29 l i n e s had TdT a c t i v i t y with 8 having >50% i n h i b i t i o n ; TdT values ranged from 0.006 t o 0.037 u n i t s . The 4 l i n e s without i n h i b i t i o n of TdT ranged from 0.007 t o 0.01 U. A l l of t h e T c e l l leukemic l i n e s (including 8392) contained TdT and were i n h i b i t e d by ATP; t h e B u r k i t t ' s l i n e was negative. Of t h e I D p a t i e n t s , 3/10 common v a r i a b l e I D , 317 ADA + SCID ( 1 ATP neg.), 111 Bruton's and 111 Wiskott-Aldrich were p o s i t i v e . A l l a t a x i a
